Evidence map›Paper›PMID 39987882›Full record

ArticleVaccine2025

WHO defeating meningitis symposium, 3rd international symposium on Streptococcus agalactiae disease (ISSAD) in Rio de Janeiro, Brazil: State-of-the-art overview of S. agalactiae meningitis.

Laura M A Oliveira, Namrata Prasad, Ruth Lynfield, Margaret Ip, Soufiane Sanou, Felipe P G Neves, Annelies Wilder-Smith, Heidi M Soeters, Kirsty Le Doare, Marie-Pierre Preziosi

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Laura M A OliveiraInstituto de Microbiologia Paulo de Goes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: lauraoliveira@micro.ufrj.br.
Namrata PrasadCenters for Disease Control and Prevention, Atlanta, United States. Electronic address: riz9@cdc.gov.
Ruth LynfieldMinnesota Department of Health, United States. Electronic address: ruth.lynfield@state.mn.us.
Margaret IpChinese University of Hong Kong, Hong Kong, China. Electronic address: margaretip@cuhk.edu.hk.
Soufiane SanouNational Institute of Public Health/Centre MURAZ, Burkina Faso.
Felipe P G NevesInstituto Biomédico, Universidade Federal Fluminense, Niterói, Brazil. Electronic address: fpgneves@id.uff.br.
Annelies Wilder-SmithWorld Health Organization, Geneva, Switzerland. Electronic address: wildersmitha@who.int.
Heidi M SoetersWorld Health Organization, Geneva, Switzerland. Electronic address: soetersh@who.int.
Kirsty Le DoareWorld Health Organization, Geneva, Switzerland; St George's University of London, London, UK; Makerere University, Johns Hopkins University, Kampala, Uganda; UK Health Security Agency, Porton Down, UK. Electronic address: kiledoar@sgul.ac.uk.
Marie-Pierre PreziosiWorld Health Organization, Geneva, Switzerland. Electronic address: preziosim@who.int.

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

A World Health Organization (WHO) Defeating Meningitis Symposium took place as part of the 3rd International Symposium on Streptococcus agalactiae disease (ISSAD) conference which was held in Rio de Janeiro, Brazil, from October 16-18, 2023. The symposium highlighted WHO's Defeating meningitis by 2030 global road map focusing on Group B Streptococcus (GBS) meningitis and provided an overview of the meningitis burden and main challenges faced to tackle the disease across the Americas, Africa, and Asia.

Indexed as

Meningitis, BacterialStreptococcal InfectionsStreptococcus agalactiaeBrazilGlobal HealthHumansStreptococcal VaccinesWorld Health OrganizationStreptococcal VaccinesGroup B StreptococcusMeningitisWHO defeating meningitis by 2030 global road map

Identifiers

PMID39987882
PMCPMC12159844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.